Innovations in genomics research are resulting in a regular stream of potential biomarkers requiring further validation before they can be translated into an actionable diagnostic test. For assay developers, access to flexible, high-quality, cost-effective multiplexing platforms to deploy this new genomic and proteomic content is critical for success.
To meet this increasing demand, Illumina offers general purpose reagents (GPRs) for use in CLIA high-complexity laboratories and companies developing diagnostic tests. These GPRs offer a truly open platform, enabling laboratories to efficiently and cost-effectively use new content to develop multiplex assays based on their preferred multiplex and methodology.
Learn more with VeraCode Beads, GPR (PDF).
General Purpose Reagents currently available